Disease-modifying anti-nephropathic drugs (DMANDs) – A definition proposed by the IWG of ERA
Home | Video pages | Webcast | Optimal RAASi in the patient with CKD/HF: interpreting guidelines through the lens of recent data
Disease-modifying anti-nephropathic drugs (DMANDs) – A definition proposed by the IWG of ERA
Targeting bone in CKD without biopsy – novel non-invasive treatment targets